Mon, Nov 24, 2014, 4:47 AM EST - U.S. Markets open in 4 hrs 43 mins


% | $
Quotes you view appear here for quick access.

Avanir Pharmaceuticals, Inc. Message Board

  • supermba_2000 supermba_2000 Nov 28, 2012 11:11 PM Flag

    Canaccord Genuity Reiterates Buy on Avanir as Drug Sales Ramp

    November 28, 2012 2:23 PM EST

    Canaccord Genuity maintained a Buy on Avanir Pharmaceuticals with a price target of $6.00 after the company reported drug sales that beat estimates. Nuedexta gross sales came in a $15.4 million, beating consensus views of $14.8 million.

    Commenting on the developments, analysts Ritu Baral said, "Recent sales trends continue to appear steady, and we foresee continued sales ramp in 2013."

    Canaccord Genuity's $6 target on Avanir Pharmaceuticals is based on a sum-of- the-parts analysis.

    Sentiment: Strong Buy

13.88+0.02(+0.14%)Nov 21 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.